Advertisement

Topics

Gastroenterology Reports

05:58 EDT 23rd October 2017 | BioPortfolio

Fred Hutchinson Cancer Research Center Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17082017] Prices from USD $250

SummaryFred Hutchinson Cancer Research Center Fred Hutchinson, a subsidiary of National Comprehensive Cancer Network, is a nonprofit organization which conducts research on the prevention, diagnose and treatment of cancer, HIV/AIDS and other life threatening diseases. It conducts research on various diseases such as cervical cancer, colorectal cancer, crohn's disease, cystic fibrosis, esophageal c...

ImmusanT Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23082017] Prices from USD $250

SummaryImmusanT Inc ImmusanT is a drug company that discovers and develops therapies for celiac disease. The company's pipeline products include Nexvax 2 and Nexvax 3. Its pipeline product Nexvax 2 is used for treating, preventing and diagnosing celiac disease. ImmusanT's pipeline products are also used for the treatment of diabetes, thyroid autoimmunity, autoimmune liver diseases, rheumatoid arth...

H. Lee Moffitt Cancer Center Research Institute Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24082017] Prices from USD $250

SummaryH Lee Moffitt Cancer Center Research Institute Inc Moffitt is a healthcare service provider that concentrates on the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services such as surgical care, fertility preservation, radiation therapy, interventional radiology, rehabilitation s...

Metastatic Prostate Cancer Epidemiology Insights to 2025 [Report Updated: 31072017] Prices from USD $2950

DelveInsight's Metastatic Prostate Cancer Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Metastatic Prostate Cancer in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Metastatic Prostate Cancer. The Report also discusses the prevailing risk factors, disease burden with special e...

Tyrosine Protein Kinase CSK C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2 Pipeline Review, H2 2017 [Report Updated: 29082017] Prices from USD $3500

Tyrosine Protein Kinase CSK C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2 Pipeline Review, H2 2017SummaryAccording to the recently published report 'Tyrosine Protein Kinase CSK Pipeline Review, H2 2017'; Tyrosine Protein Kinase CSK C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2 pipeline Target constitutes close to 14 molecules. Out of which approximately 7 ...

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5 Pipeline Review, H2 2017 [Report Updated: 29082017] Prices from USD $3500

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5 Pipeline Review, H2 2017SummaryCarcinoembryonic Antigen Related Cell Adhesion Molecule 5 Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5 Carcinoembryonic antigenrelated cell adhesion molecule 5 CEACAM5 also known as CD66e is a human gen...

Hepatic Colorectal Metastasis Pipeline Insight, 2017 [Report Updated: 31072017] Prices from USD $1250

DelveInsight's, Hepatic Colorectal MetastasisPipeline Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Hepatic Colorectal Metastasis. The report provides a complete understanding of the pipeline activities covering all clinical, preclinical and discovery stage products. A comparative pipeline therapeutics assessment of Hepatic Col...

China Cancer Test Market, Volume, Forecast By Male Female, Mortality 26 Cancer Oncology Types Market Volume to 2022 [Report Updated: 29082017] Prices from USD $2200

By the end of the year 2022, China Cancer Test Market is expected to cross US$ 24 Billion. China is the leading consumer of tobacco in the worldwide. Urban and Rural areas face high death rate due to the massive impact of growing cancer diseases in China. In order to alleviate cancer prevalence; the government focuses on several Cancer Control Programs which include prevention, early diagnosis and...

Thymus Cancer Epidemiology Insights to 2025 [Report Updated: 31072017] Prices from USD $2950

DelveInsight's Thymus Cancer Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Thymus Cancer in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Thymus Cancer. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs asso...

China Molecular Diagnostics Market, Test Volume Forecast by Oncology Test Breast Cancer, Colorectal Cancer, Prostate Cancer Infectious Disease Test Virology, HPV, Genetic Test Blood Screening, HLA [Report Updated: 28082017] Prices from USD $1200

China molecular diagnostics market is expected to be more than USD 1.5 Billion by the year 2022. As a part of the evolution of medicine in China; en route for targeted therapy and recognizing the revenue as well as profits in this new market, Diagnostics instruments are the foundation of the biotechnology industry and the pharmaceutical industry are appropriately important in molecular diagnostics...

Cancer Research UK Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25072017] Prices from USD $250

SummaryCancer Research UK CRUK is a research institution which offers clinical research services to treat cancer. The institute offers research services for womb cancer, lung cancer, bladder cancer, bone cancer, bowel cancer, brain tumours, breast cancer, carcinoid, cervical cancer, children's cancer, choriocarcinoma, chronic lymphocytic leukaemia, chronic myeloid leukaemia, colon cancer, colorect...

Global Oxaliplatin Market Research Report 20112023 [Report Updated: 22072017] Prices from USD $3240

SummaryOxaliplatin is a platinumbased anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.The global Oxaliplatin market will reach xxx Million USD in 2017 with CAGR xx% from 20182023. The objective of report is to define, segment, ...

Thyroid Cancer Epidemiology Insights to 2025 [Report Updated: 31072017] Prices from USD $2950

DelveInsight's Thyroid Cancer Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Thyroid Cancer in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Thyroid Cancer. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs a...

Calypso Biotech SA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25072017] Prices from USD $250

SummaryCalypso Biotech SA Calypso is a biopharmaceutical company that develops antibody therapies. The company's pipeline products include CALY0001 and CALY0002. Its CALY0001 therapeutic antibody is used in the treatment of Crohn's disease; and CALY0002 a humanized monoclonal antibody used in the treatment of refractory celiac disease. Its target therapy areas include gastrointestinal diseases suc...

Receptor Tyrosine Protein Kinase ERBB 4 Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1 Pipeline Review, H2 2017 [Report Updated: 08082017] Prices from USD $3500

Receptor Tyrosine Protein Kinase ERBB 4 Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1 Pipeline Review, H2 2017SummaryReceptor Tyrosine Protein Kinase ERBB 4 Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1 pipeline Target consti...

Cervical CancerMarket Insights, Epidemiology and Market Forecast2023 [Report Updated: 01032017] Prices from USD $4950

DelveInsight's Cervical Cancer Market Insights, Epidemiology and Market Forecast2023Global Report provides an overview of the disease and global market size of the Cervical Cancer for the 7MM United States, EU5 France, Germany, Italy, Spain and UK and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Cervical Cancer from 20132023. Del...

Celiac Disease Global Clinical Trials Review, H1, 2017 [Report Updated: 31052017] Prices from USD $2500

Celiac Disease Global Clinical Trials Review, H1, 2017SummaryGlobalData's clinical trial report, Celiac Disease Global Clinical Trials Review, H1, 2017" provides an overview of Celiac Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Celiac Disease. Report includes an overview of trial numbers and their average enrollment in top countries condu...

NonSmall Cell Lung Cancer Epidemiology Insights to 2025 [Report Updated: 31072017] Prices from USD $2950

DelveInsight's NonSmall Cell Lung Cancer Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of NonSmall Cell Lung Cancer in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of NonSmall Cell Lung Cancer. The Report also discusses the prevailing risk factors, disease burden with special emph...

Small Cell Lung Cancer Epidemiology Insights to 2025 [Report Updated: 31072017] Prices from USD $2950

DelveInsight's Small Cell Lung Cancer Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Small Cell Lung Cancer in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Small Cell Lung Cancer. The Report also discusses the prevailing risk factors, disease burden with special emphasis on t...

ImmusanT Inc Medical Equipment Deals and Alliances Profile [Report Updated: 12072017] Prices from USD $250

SummaryImmusanT Inc ImmusanT is a drug company that discovers and develops therapies for celiac disease. The company's pipeline products include Nexvax 2 and Nexvax 3. Its pipeline product Nexvax 2 is used for treating, preventing and diagnosing celiac disease. ImmusanT's pipeline products are also used for the treatment of diabetes, thyroid autoimmunity, autoimmune liver diseases, rheumatoid arth...

Fallopian Tube Cancer Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10072017] Prices from USD $5750

DelveInsight's Fallopian Tube Cancer Market Insights, Epidemiology and Market Forecast 2025 Reports provides an overview of the disease and global market size of the Fallopian Tube Cancer for the 7MM United States, Germany, France, Italy, Spain and UK. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Fallopian Tube Cancer forecasted market share ...

Celiac Disease Epidemiology Insights to 2023 [Report Updated: 01012017] Prices from USD $2750

DelveInsight's Celiac Disease CD Epidemiology Insights2023 report provides an overview of the Celiac Disease and current scenario of the disease in the 7MM, i.e., United States and EU5 countries France, Germany, Italy, Spain and UK and Japan. It also includes the global historical and forecasted epidemiological data for the total prevalent cases and diagnosed prevalent cases of Celiac Disease fro...

Medullary Thyroid Cancer Epidemiology Insights to 2025 [Report Updated: 31072017] Prices from USD $2950

DelveInsight's Medullary Thyroid Cancer Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Medullary Thyroid Cancer in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Medullary Thyroid Cancer. The Report also discusses the prevailing risk factors, disease burden with special emphasi...

Epithelial Ovarian Cancer Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10072017] Prices from USD $5750

DelveInsight's Epithelial Ovarian Cancer Market Insights, Epidemiology and Market Forecast 2025 Reports provides an overview of the disease and global market size of the Epithelial Ovarian Cancer for the 7MM United States, Germany, France, Italy, Spain and UK. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Epithelial Ovarian Cancer forecasted m...

Nasopharyngeal Cancer Epidemiology Insights to 2025 [Report Updated: 31072017] Prices from USD $2950

DelveInsight's Nasopharyngeal Cancer Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Nasopharyngeal Cancer in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Nasopharyngeal Cancer. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the ...

Quick Search
Advertisement
 

review and buy Gastroenterology market research data and corporate reports here